United States (US) Gastroparesis Market (2025-2031) | Industry, Outlook, Segmentation, Analysis, Companies, Growth, Trends, Competitive Landscape, Share, Forecast, Value, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Gastroparesis Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Gastroparesis Market - Industry Life Cycle

3.4 United States (US) Gastroparesis Market - Porter's Five Forces

3.5 United States (US) Gastroparesis Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Gastroparesis Market Revenues & Volume Share, By Drug Class Type, 2021 & 2031F

3.7 United States (US) Gastroparesis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about gastroparesis and its symptoms among healthcare professionals and patients

4.2.2 Growing prevalence of diabetes, a major risk factor for gastroparesis

4.2.3 Technological advancements in diagnostic methods and treatment options for gastroparesis

4.3 Market Restraints

4.3.1 Limited availability of effective treatment options for gastroparesis

4.3.2 High cost associated with gastroparesis management and treatment

4.3.3 Challenges in accurate diagnosis and management of gastroparesis due to its complex nature

6.1 United States (US) Gastroparesis Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Gastroparesis Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Gastroparesis Market Revenues & Volume, By Idiopathic, 2021- 2031F

6.1.4 United States (US) Gastroparesis Market Revenues & Volume, By Diabetic, 2021- 2031F

6.1.5 United States (US) Gastroparesis Market Revenues & Volume, By Post-Surgical, 2021- 2031F

6.1.6 United States (US) Gastroparesis Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Gastroparesis Market, By Drug Class Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Gastroparesis Market Revenues & Volume, By Prokinetic Agents, 2021- 2031F

6.2.3 United States (US) Gastroparesis Market Revenues & Volume, By Antiemetic Agents, 2021- 2031F

6.2.4 United States (US) Gastroparesis Market Revenues & Volume, By Botulinum Toxin Injection, 2021- 2031F

6.3 United States (US) Gastroparesis Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Gastroparesis Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.3.3 United States (US) Gastroparesis Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.3.4 United States (US) Gastroparesis Market Revenues & Volume, By Others, 2021- 2031F

7.1 United States (US) Gastroparesis Market Export to Major Countries

7.2 United States (US) Gastroparesis Market Imports from Major Countries

8.1 Average time from symptom onset to diagnosis of gastroparesis

8.2 Number of clinical trials and research studies focused on gastroparesis treatment

8.3 Patient satisfaction scores with current gastroparesis management options

9.1 United States (US) Gastroparesis Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Gastroparesis Market Opportunity Assessment, By Drug Class Type, 2021 & 2031F

9.3 United States (US) Gastroparesis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 United States (US) Gastroparesis Market Revenue Share, By Companies, 2024

10.2 United States (US) Gastroparesis Market Competitive Benchmarking, By Operating and Technical Parameters